Advertisement

Digestive Diseases and Sciences

, Volume 51, Issue 10, pp 1780–1782 | Cite as

De Novo Hepatocellular Carcinoma Occurring in a Transplanted Liver: Case Report and Review of the Literature

  • Anca Croitoru
  • Thomas D. Schiano
  • Myron Schwartz
  • Sasan Roayaie
  • Ruliang Xu
  • Arief Suriawinata
  • M. Isabel Fiel
Case Report

Introduction

One of the main indications for liver transplantation in patients with end-stage liver disease is hepatitis C virus (HCV)-induced cirrhosis [1, 2]. Cirrhosis from any cause may give rise to hepatocellular carcinoma (HCC). Recurrence of HCV infection in the liver allograft is almost universal and may lead to graft failure and/or cirrhosis in between 10 and 30% of cases within 5 years [3, 4, 5]. Only two cases have been previously reported in the medical literature in which HCC developed in the liver allograft in the setting of recurrent HCV and cirrhosis [6, 7]. We report an additional case of de novo HCC in a cirrhotic allograft with recurrent hepatitis C.

Case report

A 61-year-old Caucasian man underwent an orthotopic liver transplantation (OLT) on March 7, 1996, for end-stage liver disease due to HCV cirrhosis and concomitant nonalcoholic steatohepatitis. Imaging studies performed prior to OLT revealed a cirrhotic liver without focal lesions. The serum α-fetoprotein...

Keywords

Liver transplantation Immunosuppression De novo hepatocellular carcinoma Hepatitis C 

Notes

Acknowledgment

We thank Dr. Swan N. Thung for her input on the manuscript.

References

  1. 1.
    Willems M, Metselaar HJ, Tilanus HW, Schalm SW, de Man RA (2002) Liver transplantation and hepatitis C. Transpl Int 15:61–72PubMedCrossRefGoogle Scholar
  2. 2.
    Wright TL (2002) Treatment of patients with hepatitis C and cirrhosis. Hepatology 36:S185–S194PubMedCrossRefGoogle Scholar
  3. 3.
    Texeira R, Papatheodoridis GV, Borroughs AK (2001) Management of recurrent hepatitis C after liver transplantation. J Viral Hepat 8:159–168CrossRefGoogle Scholar
  4. 4.
    Facciuto M, Heidt D, Guarrera J, Bodian CA, Miller CM, Emre S, Guy SR, Fishbein TM, Schwartz ME, Sheiner PA (2000) Retransplantation for late graft failure: predictors of mortality. Liver Transpl 6:174–179PubMedGoogle Scholar
  5. 5.
    Berenguer M (2002) Natural history of recurrent hepatitis C. Liver Transpl 8:S14–S18PubMedCrossRefGoogle Scholar
  6. 6.
    Saxena R, Ye MQ, Emre S, Klion F, Nalesnik MA, Thung SN (1999) De novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitis C cirrhosis. Liver Transpl Surg 5:81–82PubMedCrossRefGoogle Scholar
  7. 7.
    Levitsky J, Faust TW, Cohen SM, Te HS (2002) Group G streptococcal bacteremia and de novo hepatocellular carcinoma after liver transplantation. Liver Transpl 8:572PubMedCrossRefGoogle Scholar
  8. 8.
    Saigal S, Norris S, Muiesan P, Rela M, Heaton N, O’Grady J (2002) Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl 8:482–487PubMedCrossRefGoogle Scholar
  9. 9.
    Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B (2001) De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl 7:S109–S118PubMedCrossRefGoogle Scholar
  10. 10.
    Frezza EE, Fung JJ, van Thiel DH (1997) Non-lymphoid cancer after liver transplantation. Hepatogastroenterology 44:1172–11781PubMedGoogle Scholar
  11. 11.
    Haagsma EB, Hagens VE, Schaapveld M, van den Berg AP, de Vries EG, Klompmaker IJ, Slooff MJ, Jansen PL (2001) Increased cancer risk after liver transplantation: a population-based study. J Hepatol 34:84–91PubMedCrossRefGoogle Scholar
  12. 12.
    Everson GT (2002) Impact of immunosuppressive therapy on recurrence of hepatitis C. Liver Transpl 8:S19–S27PubMedCrossRefGoogle Scholar
  13. 13.
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maartens G, Williams R (1996) Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334:815–820PubMedCrossRefGoogle Scholar
  14. 14.
    Sanchez EA, Marubashi S, Jung G, Levy MF, Goldstein RM, Molmenti EP, Fasola CG, Gonwa TA, Jennings LW, Brooks BK, Klintmalm GB (2002) De novo tumors after liver transplantation: A single institutional experience. Liver Transpl 8:285–291PubMedCrossRefGoogle Scholar
  15. 15.
    Jimenez C, Rodriguez D, Marques E, Loinaz C, Alonso O, Hernandez-Vallejo G, Marin L, Rodriguez F, Garcia I, Moreno L (2002) De novo tumors after orthotopic liver transplantation. Transpl Proc 34:297–298CrossRefGoogle Scholar
  16. 16.
    Ghobrial RM (2002) Retransplantation for recurrent hepatitis C. Liver Transpl 8:S38–S43PubMedCrossRefGoogle Scholar
  17. 17.
    Nissen NN, Martin P (2002) Hepatocellular carcinoma: the high risk patient. J Clin Gastroenterol 35:S79–S85PubMedCrossRefGoogle Scholar
  18. 18.
    Mithoefer AB, Supran S, Freeman RB (2002) Risk factors associated with the development of skin cancer after liver transplantation. Liver Transpl 8:939–944PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Anca Croitoru
    • 1
  • Thomas D. Schiano
    • 2
    • 3
  • Myron Schwartz
    • 2
  • Sasan Roayaie
    • 2
  • Ruliang Xu
    • 1
  • Arief Suriawinata
    • 1
  • M. Isabel Fiel
    • 1
  1. 1.The Lillian and Henry M. Stratton-Hans Popper Department of PathologyThe Mount Sinai Medical CenterNew YorkUSA
  2. 2.The Recanati-Miller Transplantation InstituteThe Mount Sinai Medical CenterNew YorkUSA
  3. 3.Adult Liver TransplantationMount Sinai Medical CenterNew YorkUSA

Personalised recommendations